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Results

4% of patients with acute CHF exacerbation die during
hospitalization
10% of patients die within 30 days of hospitalization for
acute CHF exacerbation, and 30% die within one year
25% of CHF patients are readmitted to a hospital within
one month of discharge, and risk of mortality increases
with each hospitalization
Poor performance discharging CHF exacerbations
– 93.8% admission rate
– 5th percentile nationally for percentage of CHF patients
presenting to the emergency room who are discharged
Average performance on readmission rates
– ~20% of patients readmitted after ~5 day LOS of initial
hospitalization
CHF pathway implemented in 2016, however, it doesn't
seem to make a difference in the admissions rate (Figure
1).

Figure 1

Problem Statement

The preliminary study consisted of an analysis
to determine if the pathway is being used
properly. It found that 88.0% of acute CHF
patients that were discharged appropriately
since the initiation of the pathway. Additionally,
66.7% of acute CHF admissions were
appropriately admitted since the initiation of
the pathway. More detail is shown in Table 1.
This is shown in Figure 2 below. The biggest
divergence from the pathway was that
patients were being admitted because of
practice variations within the cardiology
department.

How can a standardized, evidence-based care pathway be
modified to improve compliance in order to increase the
percentage of patients who are appropriately discharged
from the ED after presenting with an acute exacerbation of
CHF?

Methods
First, an analysis was completed to determine if
the acute CHF patients in the ED were properly
discharged per the pathway. Chart review was
done for the patient record for the specific
hospital encounter and compared against the
CHF pathway to see if the patients were properly
discharged per the pathway. Next, an analysis
was done to determine if the acute CHF patients
in the ED were properly admitted per the
pathway. The steps were then repeated for the
acute CHF patients that were admitted from the
ED, however, this time the list was compared to
see if the patients were properly being admitted
as per the pathway. The steps are outlined in
figure 2.
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Many users also would like an Epic assistance that
would help in the management of acute CHF.
New guidelines for acute CHF management have also
come out in favor of IV furosemide within 60 minutes of
patient presentation, as well as use of ultrasound to
diagnose CHF and the needy.
This was all taken into consideration when developing
and revising the pathway (Figure 4)
It is important to reduce unnecessary CHF admissions
for many reasons. This is where the SELECT
competency of values based patient centered care and
health systems come in.
–
–

Unnecessary hospitalizations for acute CHF increased mortality,
therefore reducing this what increase the quality of care.
Inpatient treatment cost over $7000 whereas outpatient treatment
is approximately $950, saving the network and patients money.

Conclusions

3.3%

administered instead
of IV NTG

Figure 2

I:O not documented

3.3%

Patient preferred

1.7%

Investigating the rate of CHF admissions from
the ED to the hospital found that there was
noncompliance of the pathway. Using
feedback from the pathway users, as well as
new guidelines for management of an acute
CHF, the original pathway was able to be
revised in order to make it simpler, and include
the new guidelines.

hospital treatment

Table 1

Figure 3

Further study is in progress to see if the
revised pathway makes a difference for many
patients presenting with acute CHF from the
ED.
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Detail

W hy are we doing this?
We have significantly higher than reported admission rate for CHF in our ER. Published data reveals a 20% discharge rate ( Storrow
IG, JACC 2014;2:269-77). LVHN currently ranks in the 5th percentile discharge rate (2% discharged). The CHF pathway will decrease
avoidable hospitalizations, reduce costs, and improve patient care.
How will it change m y practice ?
This evidence-based pathway will be my starting point for improving my patient care with CHF

Pulmonary Edema/Acutely
Decompensated HF
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Door to
Diuretic
tracking

Additionally, feedback from the pathway users
was gathered. A survey was sent out asking the
users to rate the pathway as well as provide
feedback about the pathway and what the users
preferred to see in the ED.

Start IV Lasix (2 x daily oral
dose)
Add NTD for SBP > 180

Track I:O’s
Goal urine output >250mL
(estimate can be accepted)

Admit to Hospital
Medicine

Using the data collected from the inlier and outlier
analysis, and the feedback gathered from the
residents, an alternative pathway was created.

NTG paste

Pathway users filled out a survey to determine what
their thoughts are of the pathway. Many of the users
found the pathway too complicated to follow for the ED.
Additionally, feedback was gathered from the users.
Many said that there was practice variations between
the ED physicians and the cardiologists.

•

against the consulted
pathway

•

•

that were admitted
66.6%

The study found that there was noncompliance with the
CHF pathway. Around one third of the admissions to
the hospital were not following the pathway.

•

Additionally, a survey was sent to the pathway
users to determine the thoughts on the
pathway. It was found that the pathway was
too complicated to use in the ED, as well as
practice variations amongst the ED physicians
and the cardiologist for when the patients
require admission. Part of the survey is shown
Patients with acute CHF seen in ED Rate
in figure 3.
Admitted to hospital per pathway

•

NO

YES

NO

YES

Observation

1. Discharge with 2 day
followup with cardiology
2. Increase the diuretic

Figure 4
LV PG CC fo llow u p # is 610 -4 02 -313 0
LV PG M uh le nb e rg f ollow up # is 484 -884 -7 807
H CG fo llow up # is 6 10-77 0 -2200

1. Incre ase dose or f req ue n cy of loop
diur e tic by 50 – 10 0 % pe r d a y f o r 1-2 day s
2. Orde r C MP p rior to f o llow up
appoint m e nt w it h Car diolog ist
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